Back to Search Start Over

Relevance of cutoff on a 4th generation ELISA performance in the false positive rate during HIV diagnostic in a low HIV prevalence setting.

Authors :
Chacón L
Mateos ML
Holguín Á
Source :
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology [J Clin Virol] 2017 Jul; Vol. 92, pp. 11-13. Date of Electronic Publication: 2017 Apr 26.
Publication Year :
2017

Abstract

Background: Despite the high specificity of fourth-generation enzyme immunoassays (4th-gen-EIA) for screening during HIV diagnosis, their positive predictive value is low in populations with low HIV prevalence. Thus, screening should be optimized to reduce false positive results.<br />Objectives: The influence of sample cutoff (S/CO) values by a 4th-gen-EIA with the false positive rate during the routine HIV diagnosis in a low HIV prevalence population was evaluated.<br />Study Design: A total of 30,201 sera were tested for HIV diagnosis using Abbott Architect <superscript>®</superscript> HIV-Ag/Ab-Combo 4th-gen-EIA at a hospital in Spain during 17 months. Architect S/CO values were recorded, comparing the HIV-1 positive results following Architect interpretation (S/CO≥1) with the final HIV-1 diagnosis by confirmatory tests (line immunoassay, LIA and/or nucleic acid test, NAT). ROC curve was also performed.<br />Results: Among the 30,201 HIV performed tests, 256 (0.85%) were positive according to Architect interpretation (S/CO≥1) but only 229 (0.76%) were definitively HIV-1 positive after LIA and/or NAT. Thus, 27 (10.5%) of 256 samples with S/CO≥1 by Architect were false positive diagnose. The false positive rate decreased when the S/CO ratio increased. All 19 samples with S/CO ≤10 were false positives and all 220 with S/CO>50 true HIV-positives. The optimal S/CO cutoff value provided by ROC curves was 32.7. No false negative results were found.<br />Conclusions: We show that very low S/CO values during HIV-1 screening using Architect can result HIV negative after confirmation by LIA and NAT. The false positive rate is reduced when S/CO increases.<br /> (Copyright © 2017 Elsevier B.V. All rights reserved.)

Details

Language :
English
ISSN :
1873-5967
Volume :
92
Database :
MEDLINE
Journal :
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology
Publication Type :
Academic Journal
Accession number :
28501753
Full Text :
https://doi.org/10.1016/j.jcv.2017.04.014